10 July 2024
Graft Polymer (UK) Plc
(the "Company")
Admission, PDMR share dealings
and
Total Voting Rights
Further to the Company's announcement of 3 July 2024, the Company announces that a total of 2,171,166,667 new Ordinary Shares, including the 1,800,000,000 Placing Shares, have been admitted to trading on the Main Market of the London Stock Exchange and to listing on the Standard Segment of the FCA's Official List this morning.
Notifications required by UK MAR are set out below.
Total Voting Rights
Following Admission, the Company's issued ordinary share capital consists of 2,295,930,633 Ordinary Shares with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 2,295,930,633. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Capitalised terms in this announcement shall have the meanings ascribed to them in the Company's announcement of 3 July 2024 unless stated otherwise.
Enquiries:
Graft Polymer (UK) Plc:
Anthony Tennyson, CEO and Executive Director: anthonytennyson@graftpolymer.com
Yifat Steuer, CFO and Executive Director: yifat@graftpolymer.com
Allenby Capital (Broker):
Phone: +44 (0) 20 3328 5656
Nick Naylor / Liz Kirchner / James Reeve (Corporate Finance)
Guy McDougall (Sales)
About Graft Polymer (UK) Plc
Graft Polymer (UK) Plc (LSE: GPL) is an innovative developer of biopolymer drug delivery systems dedicated to assisting biopharmaceutical companies in enhancing the effectiveness of their therapeutics. Our proprietary patented platform, a bioabsorbable self-nanoemulsifying drug delivery system (SNEDDS), represents a cutting-edge solution in drug delivery technology. By integrating active pharmaceutical ingredients (APIs) into our novel, patented delivery systems, we enable clients to improve the bioavailability, pharmacokinetics, and stability of their therapeutics.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
| a) | Name | Nicholas Nelson
| ||||||
| 2. | Reason for the Notification | |||||||
| a) | Position/status | Director | ||||||
| b) | Initial notification/Amendment | Initial Notification | ||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a) | Name | Graft Polymer (UK) plc | ||||||
| b) | LEI | 2138005PH7OJRCRPUD88 | ||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of £0.001 each | ||||||
| Identification code | Identification code (ISIN) for Graft Polymer (UK) plc ordinary shares: GB00BMD1Z199 | |||||||
| b) | Nature of the transaction | Placing Participation | ||||||
| c) | Price(s) and volume(s) |
| ||||||
| d) | Aggregated information: -Aggregated volume -Price | n/a | ||||||
| e) | Date of the transaction | 10 July 2024 | ||||||
| f) | Place of the transaction | Outside of a trading venue | ||||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
| a) | Name | Nicholas Nelson
| ||||||
| 2. | Reason for the Notification | |||||||
| a) | Position/status | Director | ||||||
| b) | Initial notification/Amendment | Initial Notification | ||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a) | Name | Graft Polymer (UK) plc | ||||||
| b) | LEI | 2138005PH7OJRCRPUD88 | ||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of £0.001 each | ||||||
| Identification code | Identification code (ISIN) for Graft Polymer (UK) plc ordinary shares: GB00BMD1Z199 | |||||||
| b) | Nature of the transaction | Loan Conversion Shares | ||||||
| c) | Price(s) and volume(s) |
| ||||||
| d) | Aggregated information: -Aggregated volume -Price |
n/a | ||||||
| e) | Date of the transaction | 10 July 2024 | ||||||
| f) | Place of the transaction | Outside of a trading venue | ||||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
| a) | Name | 1) Nicholas Nelson 2) Pavel Kobzev 3) Yifat Steuer | ||||||
| 2. | Reason for the Notification | |||||||
| a) | Position/status | Directors | ||||||
| b) | Initial notification/Amendment | Initial Notification | ||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a) | Name | Graft Polymer (UK) plc | ||||||
| b) | LEI | 2138005PH7OJRCRPUD88 | ||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of £0.001 each | ||||||
| Identification code | Identification code (ISIN) for Graft Polymer (UK) plc ordinary shares: GB00BMD1Z199 | |||||||
| b) | Nature of the transaction | Issuance of Fee Shares | ||||||
| c) | Price(s) and volume(s) |
| ||||||
| d) | Aggregated information: -Aggregated volume -Price | n/a | ||||||
| e) | Date of the transaction | 10 July 2024 | ||||||
| f) | Place of the transaction | Outside of a trading venue | ||||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
| a) | Name | 1) Victor Bolduev 2) Yifat Steuer 3) Pavel Kobzev | ||||||||
| 2. | Reason for the Notification | |||||||||
| a) | Position/status | Directors | ||||||||
| b) | Initial notification/Amendment | Initial Notification | ||||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
| a) | Name | Graft Polymer (UK) plc | ||||||||
| b) | LEI | 2138005PH7OJRCRPUD88 | ||||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of £0.001 each | ||||||||
| Identification code | Identification code (ISIN) for Graft Polymer (UK) plc ordinary shares: GB00BMD1Z199 | |||||||||
| b) | Nature of the transaction | Issuance of Management Shares | ||||||||
| c) | Price(s) and volume(s) |
| ||||||||
| d) | Aggregated information: -Aggregated volume -Price | n/a | ||||||||
| e) | Date of the transaction | 10 July 2024 | ||||||||
| f) | Place of the transaction | Outside of a trading venue | ||||||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Nicholas Nelson
| ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Director | ||||
| b) | Initial notification/Amendment | Initial Notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Graft Polymer (UK) plc | ||||
| b) | LEI | 2138005PH7OJRCRPUD88 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of £0.001 each | ||||
| Identification code | Identification code (ISIN) for Graft Polymer (UK) plc ordinary shares: GB00BMD1Z199 | |||||
| b) | Nature of the transaction | Grant of Lender Warrants | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information: -Aggregated volume -Price | n/a | ||||
| e) | Date of the transaction | 10 July 2024 | ||||
| f) | Place of the transaction | Outside of a trading venue | ||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
| a) | Name | 1) Nicholas Nelson 2) Yifat Steuer | ||||||
| 2. | Reason for the Notification | |||||||
| a) | Position/status | Directors | ||||||
| b) | Initial notification/Amendment | Initial Notification | ||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a) | Name | Graft Polymer (UK) plc | ||||||
| b) | LEI | 2138005PH7OJRCRPUD88 | ||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of £0.001 each | ||||||
| Identification code | Identification code (ISIN) for Graft Polymer (UK) plc ordinary shares: GB00BMD1Z199 | |||||||
| b) | Nature of the transaction | Grant of Director Warrants | ||||||
| c) | Price(s) and volume(s) |
| ||||||
| d) | Aggregated information: -Aggregated volume -Price | n/a | ||||||
| e) | Date of the transaction | 10 July 2024 | ||||||
| f) | Place of the transaction | Outside of a trading venue | ||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
